K. Koch

775 total citations
27 papers, 515 citations indexed

About

K. Koch is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Nephrology. According to data from OpenAlex, K. Koch has authored 27 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Molecular Biology and 4 papers in Nephrology. Recurrent topics in K. Koch's work include Analytical Methods in Pharmaceuticals (4 papers), Pharmacology and Obesity Treatment (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). K. Koch is often cited by papers focused on Analytical Methods in Pharmaceuticals (4 papers), Pharmacology and Obesity Treatment (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). K. Koch collaborates with scholars based in Germany, United States and Austria. K. Koch's co-authors include Karl Horvath, Hilda Bastian, Andrea Siebenhofer, Klaus Jeitler, Ralf Bender, S Lange, W. Schaumann, U. Abshagen, Uwe Michel and Andreas Wellmer and has published in prestigious journals such as The Journal of Infectious Diseases, Naunyn-Schmiedeberg s Archives of Pharmacology and European Journal of Clinical Pharmacology.

In The Last Decade

K. Koch

23 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. Koch Germany	10	213	142	97	80	73	27	515
L. Laursen Denmark	17	50 0.2×	553 3.9×	97 1.0×	10 0.1×	195 2.7×	43	1.1k
Melisa Cooper United Kingdom	12	28 0.1×	28 0.2×	28 0.3×	84 1.1×	166 2.3×	20	583
Agneta K. Hurst United States	8	75 0.4×	51 0.4×	87 0.9×	29 0.4×	56 0.8×	13	385
MR Law United Kingdom	6	103 0.5×	81 0.6×	108 1.1×	22 0.3×	48 0.7×	6	662
Nathan Rudolph United States	12	21 0.1×	50 0.4×	159 1.6×	16 0.2×	44 0.6×	22	555
Alexandra Carls Germany	7	49 0.2×	40 0.3×	138 1.4×	11 0.1×	197 2.7×	13	580
Julia Botha South Africa	15	29 0.1×	32 0.2×	139 1.4×	64 0.8×	70 1.0×	41	525
Rachel Ryu United States	10	67 0.3×	48 0.3×	72 0.7×	22 0.3×	26 0.4×	18	438
Zahra Vahedpoor Iran	10	55 0.3×	38 0.3×	22 0.2×	34 0.4×	95 1.3×	15	389
Ganesh Rao United States	12	110 0.5×	104 0.7×	279 2.9×	47 0.6×	37 0.5×	28	837

Countries citing papers authored by K. Koch

Since Specialization

Citations

This map shows the geographic impact of K. Koch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Koch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Koch more than expected).

Fields of papers citing papers by K. Koch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Koch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Koch. The network helps show where K. Koch may publish in the future.

Co-authorship network of co-authors of K. Koch

This figure shows the co-authorship network connecting the top 25 collaborators of K. Koch. A scholar is included among the top collaborators of K. Koch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Koch. K. Koch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Büchter, Roland Brian, et al.. (2018). Darmkrebsfrüherkennung. Der Gastroenterologe. 14(1). 18–23. 3 indexed citations

Frei, U & K. Koch. (2015). Fever and Shock during Haemofiltration. Contributions to nephrology. 36. 107–114.

Scheuermann, E., W Fassbinder, U Frei, K. Koch, & C. A. Baldamus. (2015). Eosinophilia in Hemodialysis. Contributions to nephrology. 36. 133–138.

Koch, K., Simone Thomas, & Jürgen Windeler. (2014). IGeL oder Nicht-IGeL. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 57(3). 334–342.

Horvath, Karl, K. Koch, Klaus Jeitler, et al.. (2010). Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis. BMJ. 340(apr01 1). c1395–c1395. 225 indexed citations

Koch, K., et al.. (2009). Methodenvorschlag des IQWiG zur Kosten-Nutzen-Bewertung von medizinischen Verfahren. Das Gesundheitswesen. 71(S 01). S34–S40. 2 indexed citations

Koch, K.. (2003). Schering uses German medical association to promote HRT. BMJ. 326(7400). 1161.2–1161.2. 9 indexed citations

Nau, Roland, Andreas Wellmer, Adriana Soto, et al.. (1999). Rifampin Reduces Early Mortality in ExperimentalStreptococcus pneumoniaeMeningitis. The Journal of Infectious Diseases. 179(6). 1557–1560. 83 indexed citations

Frost, J. W., et al.. (1987). Untersuchungen zur Vereinheitlichung des Neutralisationstests zur Diagnose der Aujeszkyschen Krankheit. OpenAgrar. 3 indexed citations

10.

Schümichen, C., et al.. (1980). Binding of technetium-99m to plasma proteins: influence on the distribution of Tc-99m phosphate agents.. PubMed. 21(11). 1080–5. 9 indexed citations

11.

Abshagen, U., W. Bablok, K. Koch, et al.. (1979). Disposition pharmacokinetics of bezafibrate in man. European Journal of Clinical Pharmacology. 16(1). 31–38. 50 indexed citations

12.

Abshagen, U., et al.. (1976). ISolation and identification of a sulfur-containing metabolite of spironolactone from human urine. Steroids. 28(4). 467–480. 11 indexed citations

13.

Schaumann, W., et al.. (1973). Extrarenal actions of aldosterone antagonists in guinea pigs. Naunyn-Schmiedeberg s Archives of Pharmacology. 279(1). 9–18. 7 indexed citations

14.

Koch, K., et al.. (1973). ?-Methyl-digoxin. Naunyn-Schmiedeberg s Archives of Pharmacology. 279(3). 211–226. 4 indexed citations

15.

Ritz, Eberhard, et al.. (1973). Aktuelle Probleme der subtotalen Parathyreoidektomie bei Hämodialysepatienten. DMW - Deutsche Medizinische Wochenschrift. 98(10). 484–496. 4 indexed citations

16.

Schaumann, W., et al.. (1972). ?-Methyl-digoxin. Naunyn-Schmiedeberg s Archives of Pharmacology. 272(1). 32–45. 5 indexed citations

17.

Schaumann, W., et al.. (1972). ?-Methyl-digoxin. Naunyn-Schmiedeberg s Archives of Pharmacology. 272(1). 46–64. 9 indexed citations

18.

Schulz, Eberhard, K. Koch, & F. H. Schmidt. (1971). Ursachen der Potenzierung der hypoglykmischen Wirkung von Sulfonylharnstoff-Derivaten durch Medikamente: II. Pharmakokinetik und Metabolismus von Glibenclamid (HB 419) in Gegenwart von Phenylbutazon. European Journal of Clinical Pharmacology. 4(1). 32–37. 4 indexed citations

19.

Schulz, Eberhard, et al.. (1971). [Potentiation of the hypoglycemic effect of sulfonylurea derivatives by drugs. II. Pharmacokinetics and metabolism of glibenclamide (HB 419) in presence of phenylbutazone].. European Journal of Clinical Pharmacology. 4(1). 32–7. 6 indexed citations

20.

Koch, K., et al.. (1971). Ursachen der Potenzierung der hypoglyk�mischen Wirkung von Sulfonylharnstoff-Derivaten durch Medikamente. European Journal of Clinical Pharmacology. 4(1). 32–37. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact